Copyright Reports & Markets. All rights reserved.

Global Hydroxytryptamine Receptor Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hydroxytryptamine Receptor Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 HTR6
      • 1.4.3 HTR2B
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Hydroxytryptamine Receptor Market Share by Application (2014-2025)
      • 1.5.2 Attention Deficit Hyperactivity Disorder
      • 1.5.3 Psychiatric Disorders
      • 1.5.4 Alzheimers Disease
      • 1.5.5 Chronic Obstructive Pulmonary Disease
      • 1.5.6 Memory Impairment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Hydroxytryptamine Receptor Market Size
    • 2.2 Hydroxytryptamine Receptor Growth Trends by Regions
      • 2.2.1 Hydroxytryptamine Receptor Market Size by Regions (2014-2025)
      • 2.2.2 Hydroxytryptamine Receptor Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Hydroxytryptamine Receptor Market Size by Manufacturers
      • 3.1.1 Global Hydroxytryptamine Receptor Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Hydroxytryptamine Receptor Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Hydroxytryptamine Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hydroxytryptamine Receptor Key Players Head office and Area Served
    • 3.3 Key Players Hydroxytryptamine Receptor Product/Solution/Service
    • 3.4 Date of Enter into Hydroxytryptamine Receptor Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Hydroxytryptamine Receptor Market Size by Type (2014-2019)
    • 4.2 Global Hydroxytryptamine Receptor Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Hydroxytryptamine Receptor Market Size (2014-2019)
    • 5.2 Hydroxytryptamine Receptor Key Players in United States
    • 5.3 United States Hydroxytryptamine Receptor Market Size by Type
    • 5.4 United States Hydroxytryptamine Receptor Market Size by Application

    6 Europe

    • 6.1 Europe Hydroxytryptamine Receptor Market Size (2014-2019)
    • 6.2 Hydroxytryptamine Receptor Key Players in Europe
    • 6.3 Europe Hydroxytryptamine Receptor Market Size by Type
    • 6.4 Europe Hydroxytryptamine Receptor Market Size by Application

    7 China

    • 7.1 China Hydroxytryptamine Receptor Market Size (2014-2019)
    • 7.2 Hydroxytryptamine Receptor Key Players in China
    • 7.3 China Hydroxytryptamine Receptor Market Size by Type
    • 7.4 China Hydroxytryptamine Receptor Market Size by Application

    8 Japan

    • 8.1 Japan Hydroxytryptamine Receptor Market Size (2014-2019)
    • 8.2 Hydroxytryptamine Receptor Key Players in Japan
    • 8.3 Japan Hydroxytryptamine Receptor Market Size by Type
    • 8.4 Japan Hydroxytryptamine Receptor Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Hydroxytryptamine Receptor Market Size (2014-2019)
    • 9.2 Hydroxytryptamine Receptor Key Players in Southeast Asia
    • 9.3 Southeast Asia Hydroxytryptamine Receptor Market Size by Type
    • 9.4 Southeast Asia Hydroxytryptamine Receptor Market Size by Application

    10 India

    • 10.1 India Hydroxytryptamine Receptor Market Size (2014-2019)
    • 10.2 Hydroxytryptamine Receptor Key Players in India
    • 10.3 India Hydroxytryptamine Receptor Market Size by Type
    • 10.4 India Hydroxytryptamine Receptor Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Hydroxytryptamine Receptor Market Size (2014-2019)
    • 11.2 Hydroxytryptamine Receptor Key Players in Central & South America
    • 11.3 Central & South America Hydroxytryptamine Receptor Market Size by Type
    • 11.4 Central & South America Hydroxytryptamine Receptor Market Size by Application

    12 International Players Profiles

    • 12.1 Adamed
      • 12.1.1 Adamed Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Hydroxytryptamine Receptor Introduction
      • 12.1.4 Adamed Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.1.5 Adamed Recent Development
    • 12.2 Avineuro Pharmaceutical
      • 12.2.1 Avineuro Pharmaceutical Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Hydroxytryptamine Receptor Introduction
      • 12.2.4 Avineuro Pharmaceutical Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.2.5 Avineuro Pharmaceutical Recent Development
    • 12.3 Axovant Sciences
      • 12.3.1 Axovant Sciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Hydroxytryptamine Receptor Introduction
      • 12.3.4 Axovant Sciences Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.3.5 Axovant Sciences Recent Development
    • 12.4 Biotie Therapies
      • 12.4.1 Biotie Therapies Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Hydroxytryptamine Receptor Introduction
      • 12.4.4 Biotie Therapies Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.4.5 Biotie Therapies Recent Development
    • 12.5 Celon Pharma
      • 12.5.1 Celon Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Hydroxytryptamine Receptor Introduction
      • 12.5.4 Celon Pharma Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.5.5 Celon Pharma Recent Development
    • 12.6 Galenea Corp
      • 12.6.1 Galenea Corp Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Hydroxytryptamine Receptor Introduction
      • 12.6.4 Galenea Corp Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.6.5 Galenea Corp Recent Development
    • 12.7 H. Lundbeck
      • 12.7.1 H. Lundbeck Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Hydroxytryptamine Receptor Introduction
      • 12.7.4 H. Lundbeck Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.7.5 H. Lundbeck Recent Development
    • 12.8 Reviva Pharmaceuticals
      • 12.8.1 Reviva Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Hydroxytryptamine Receptor Introduction
      • 12.8.4 Reviva Pharmaceuticals Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.8.5 Reviva Pharmaceuticals Recent Development
    • 12.9 Suven Life Sciences
      • 12.9.1 Suven Life Sciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Hydroxytryptamine Receptor Introduction
      • 12.9.4 Suven Life Sciences Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.9.5 Suven Life Sciences Recent Development
    • 12.10 Teva Pharmaceutical Industries Ltd
      • 12.10.1 Teva Pharmaceutical Industries Ltd Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Hydroxytryptamine Receptor Introduction
      • 12.10.4 Teva Pharmaceutical Industries Ltd Revenue in Hydroxytryptamine Receptor Business (2014-2019)
      • 12.10.5 Teva Pharmaceutical Industries Ltd Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Hydroxytryptamine receptors are a group of G-protein coupled receptors and ligand gated ion channels, which are found in the peripheral and central nervous system. These receptors influence various biological and neurological processes such as aggression, anxiety, learning, mood, nausea, sleep, and cognition.
      Due to the unique properties, hydroxytryptamine receptors are used in a variety of drugs such as antidepressants, antipsychotics, antimigraine agents, hallucinogens, and entactogens.
      In 2018, the global Hydroxytryptamine Receptor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Hydroxytryptamine Receptor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hydroxytryptamine Receptor development in United States, Europe and China.

      The key players covered in this study
      Adamed
      Avineuro Pharmaceutical
      Axovant Sciences
      Biotie Therapies
      Celon Pharma
      Galenea Corp
      H. Lundbeck
      Reviva Pharmaceuticals
      Suven Life Sciences
      Teva Pharmaceutical Industries Ltd

      Market segment by Type, the product can be split into
      HTR6
      HTR2B
      Others

      Market segment by Application, split into
      Attention Deficit Hyperactivity Disorder
      Psychiatric Disorders
      Alzheimers Disease
      Chronic Obstructive Pulmonary Disease
      Memory Impairment

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hydroxytryptamine Receptor status, future forecast, growth opportunity, key market and key players.
      To present the Hydroxytryptamine Receptor development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Hydroxytryptamine Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now